Peripheral Arterial Disease Trial, Recruiting NCT06264843 Sponsor: Medistim ASA Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06264843
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have peripheral artery disease (reduced blood flow in the legs) along with rest pain, gangrene, or a leg wound that has not healed for more than 2 weeks — a condition known as chronic limb-threatening ischemia.
  • People whose blocked or narrowed arteries are located below the knee (in the lower leg area).
  • People who have a suitable artery below the knee that a surgeon can connect a bypass graft to, with one clear blood flow path between the knee and ankle (confirm with trial site).
  • People who have enough of their own vein available (confirmed by a pre-surgery vein scan) to be used as the bypass graft.
  • People who understand what the procedure involves, are willing to follow the study requirements, attend follow-up appointments, and agree to take part in writing.

Who may not be able to join:

  • People whose bypass surgery would use an artificial graft or a donated (preserved) vein rather than their own vein.
  • People whose artery blockage is caused by something other than a build-up of fatty deposits in the artery walls.
  • People whose life expectancy is estimated to be less than 2 years.
  • People who have a psychological, developmental, physical, or emotional condition that the investigator believes could interfere with surgery or with attending follow-up visits.
  • People who have any other condition that the investigator believes should prevent participation.
  • People who the investigator believes are at too high a risk for serious complications during open surgery.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4790892713

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medistim ASA
Registry
ClinicalTrials.gov
Start date
14 November 2024
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Primary graft patency rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov